XML 70 R54.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Operations Information (Tables)
12 Months Ended
Dec. 31, 2022
Consolidated Statements of Operations Information  
Schedule of group's revenue

Years ended December 31:

    

2022

    

2021

    

2020

Royalty, goods and products and services

$

52,218

$

60,201

$

48,441

Interest

 

3,712

 

405

 

531

Dividends

268

244

Gain on securities, net

758

Other, including medical and real estate sectors

7,491

10,441

9,702

Revenue

$

63,689

$

71,291

$

59,432

Schedule of group's costs of sales and services comprised

Years Ended December 31:

    

2022

    

2021

    

2020

Royalty, goods and products and services

$

23,677

$

22,933

$

22,102

(Reversal of) write-down of inventories

(21)

(19)

469

Gain on derivative contracts, net

(1,376)

Fair value gain on investment property, net of write-down of real estate for sale

(96)

(407)

(757)

(Gain) loss on dispositions of subsidiaries, net

(264)

546

Gains on settlements and derecognition of liabilities

(69)

(390)

(2,600)

Change in fair value of loan payable measured at FVTPL

141

1,616

549

Losses on securities, net

2,436

2,320

Other, including medical and real estate sectors

4,078

6,241

6,561

Total costs of sales and services

$

29,882

$

30,918

$

26,870

Schedule of costs of sales and services

Years ended December 31:

    

2022

    

2021

    

2020

Inventories as costs of goods sold (including depreciation expenses allocated to costs of goods sold)

$

80

$

3,488

$

5,041

Schedule of Group's credit losses

Years ended December 31:

    

2022

    

2021

    

2020

(Reversal of) credit losses on loans and receivables and guarantees, net

 

$

(47)

$

88

 

$

(3,108)

Schedule of Gain on Disposition of subsidiaries

Years Ended December 31:

 

2022

 

2021

 

2020

Net (liabilities) assets in excess of considerations received

 

$

(273)

 

$

 

$

331

Reclassification adjustment for the exchange differences upon dispositions of subsidiaries

9

215

(Gain) loss on dispositions of subsidiaries, net (see Note 28)

 

$

(264)

 

$

 

$

546

Schedule of selling, general and administrative expenses

Years ended December 31:

    

2022

    

2021

    

2020

Compensation (wages and salaries)

$

4,443

$

4,551

$

4,083

Legal and professional

 

6,983

 

6,395

6,794

Accounting

885

1,238

1,294

Consulting and fees

6,529

3,423

2,836

Depreciation and amortization

784

481

557

Office

748

948

708

Reimbursement of expenses (net of recovery)

5,607

1,018

257

Other

2,501

3,090

3,372

$

28,480

$

21,144

$

19,901

Schedule of nature of expenses incurred in continuing operations

Years Ended December 31:

    

2022

    

2021

    

2020

Depreciation, depletion and amortization

$

10,699

$

11,023

$

11,470

Employee benefits expenses*

 

7,194

 

6,922

 

7,253

Expenses for defined contribution plans and similar plans

278

253

123

Termination benefits

394

*     Employee benefits expenses do not include the directors’ fees of the Company. For directors’ fees, see Note 25.